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Abstract
Development and activation of immune cells are
submitted to hormonal influences, as illustrated by the
roles of corticosteroids in thymus, pregnancy-related
estrogens in B-cell development, or prolactin (PRL) on
T-cell generation and function. We have analyzed the
putative role of PRL in B lymphopoiesis and
differentiation. We chose as an experimental model the
interleukin (IL)-3 dependent BaF-3 pro-B cell line,
which was transfected with the rat long form of the
PRL receptor (PRL-R) and transferred from IL-3- to
PRL-enriched media. When stimulated with PRL, the
PRL-R transfectants underwent some changes
characteristic of B-cell differentiation: (a) IL-2R a chain
became positively controlled by PRL; (b) antiapoptotic
Bcl-2 protein was induced by PRL in a dose-dependent
manner; and (c) transcription of the pre-B cell receptor
encoding the l5 gene was strongly up-regulated. We
attempted to evaluate the differentiation-promoting
activity of PRL in more physiological conditions, and
the presence of PRL-R in bone marrow B-cell
precursors was revealed. Furthermore, PRL promoted
significant expansions of defined B-lineage cell
populations in short-term bone marrow cell cultures.
These findings suggest that PRL, in collaboration with
other cytokines and hormonal influences, modulates
B-cell development.
Introduction
PRL3 is a polypeptide hormone with structural polymorphism
and multiple sites of synthesis. Because PRL-R is ubiqui-
tously expressed, PRL modulates a variety of physiological
functions that go from the development of the mammary
gland and lactation to immune regulation (reviewed in Ref. 1).
The PRL-R is a member of the type I cytokine receptor
superfamily, which includes those for growth hormone, IL-2
to IL-7, erythropoietin, granulocyte-colony stimulating factor,
granulocyte/macrophage-colony stimulating factor, and oth-
ers, and it has no intrinsic enzymatic activity (2). Three dif-
ferent forms of PRL-R have been described; the short and
the long forms are generated by alternative RNA splicing,
and an intermediate form found in the Nb2 rat thymoma cell
line is produced through a partial in-frame deletion (3). Upon
interaction with the hormone, receptor dimerization and
tyrosine phosphorylation of latent signaling proteins are in-
duced. The receptor itself, the Jak and Src families of
tyrosine kinases (4, 5), as well as Vav and Grb2/Sos-Ras-
Raf-mitogen-activated protein kinase and Jak-STAT signal
transduction cascades become activated (Refs. 6–8, and
references within), leading to cellular proliferation and/or dif-
ferentiation. The set of Jak-Stat activated by each cytokine
could be, at least in part, responsible for their specific phys-
iological actions (reviewed in Ref. 9). PRL and its receptors
have been detected in mature lymphocytes and in thymo-
cytes (reviewed in Ref. 10). There, PRL can induce prolifer-
ative responses, accompanied by the expression of IL-2
receptors and secretion of IL-2 and IFN-g (11, 12). The avail-
able information on a putative role of PRL pathways in
lymphoid differentiation is limited; most of the studies have
been carried out in in vitro Nb2 thymoma cells, where PRL is
a mitogen inducing the expression of growth-related genes
(reviewed in Ref. 10). PRL has been also implicited in the
development and activation of other immunological cell
types such as macrophages, neutrophils, and erythrocytes
(10, 13). PRL-R was thus detected in thymocytes and thymic
epithelial cells (14). Whereas PRL had mitogenic activity in
mature T cells (15) and increased the numbers of antigen-
specific T cells in vivo (16). PRL further contributed to T-cell-
dependent autoimmunity in well-established murine models
(17). No PRL activity has been characterized, however, in the
B-cell lineages, although the PRL-R is expressed in mature B
lymphocytes (18). PRL-controlling Pit-1/GHF-1 transcription
factor has also been detected in normal BM (19).
B-cell lymphopoiesis is a complex process evolving
through ordered stages of differentiation that are controlled
by transcription factors, lineage-specific gene products (e.g.,
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PBCR-encoding genes and immunoglobulin loci-derived
clonotypes), stromal cell-progenitor interactions, and para-
crine/endocrine factors (reviewed in Ref. 20). In this context,
the study of pregnant mice has revealed a negative regula-
tory role of estrogens in BM-derived B-cell generation (21).
Androgen receptors are also expressed by immature B cells
as well as by BM stromal cells, and androgens may also
modulate B-cell development in male mice (22, 23). Also,
insulin-like growth factor type I secreted by stromal cells can
stimulate the differentiation to cytoplasmic m-positive pre-B
cells in short-term BM cell cultures (24). Here we have stud-
ied the putative involvement of PRL-driven signals in mouse
B-cell differentiation. We analyzed the influence of PRL in
B-cell differentiation by transfecting the rat PRL-R on the
IL-3-dependent BaF-3 pro-B cell line (25). BaF-3 cells trans-
fected with the rat PRL-R, so-called W53 cells, were selected
and grown in PRL-enriched media. Several molecular
changes related to B-cell differentiation in W53 cells (l5,
IL-2R a, and Bcl-2) were studied, and the results revealed
that PRL signaling on BaF-3 pro-B cells promoted significant
features of B-cell differentiation in them. PRL-R expression
was found in normal mouse BM B-cell precursors, where
PRL promoted increases in defined B-lineage cell popula-
tions in short-term cultures of BM. These data suggest that
PRL might influence normal B-cell differentiation in the
mouse.
Results
IL-3-dependent BaF-3 pro-B Cells Change to PRL De-
pendence upon Transfection of the PRL-R Gene. To test
for a putative role of the PRL pathway on B-cell differentia-
tion, we performed transfection experiments in the BaF-3
pro-B cell line that did not express the PRL-R (Fig. 1A). We
introduced the long form of the rat PRL-R into BaF-3 cells by
means of the retroviral-encoding promoter of the pBABE-
Puro plasmid. After selection of transfected cells with puro-
mycin, the W53 cells were transferred to PRL-enriched me-
dium. Immunoprecipitation of PRL-R with the U5 mAb
revealed a specific Mr 100,000 protein that was absent in
BaF-3 cells transfected with the empty vector (Fig. 1A). This
is in agreement with data published previously (4). PRL-R
transfection was functional in W53 cells because these cells
proliferated in IL-3-deprived, PRL-enriched medium in a
dose-dependent manner (Fig. 1B). In contrast, BaF-3 cells
cultured under the same conditions suffered apoptosis after
12–18 h, as determined by the typical DNA fragmentation
laddering pattern of this process (data not shown). We thus
conclude that PRL was efficient in maintaining the survival/
proliferation machinery of BaF-3 pro-B cells transfected with
the PRL-R in the absence of IL-3.
IL-2R a Chain Expression Is PRL Dependent in W53
Cells. Among the other B-lineage-specific cell surface
markers tested (CD43, BP-1, and others; data not shown),
BaF-3 cells expressed moderate levels of the IL-2R a chain
(CD25; Fig. 2, upper histogram), probably under the control
of IL-3-driven signals, as it has been shown for other hemo-
poietic cells (26). When W53 cells were grown in IL-3-
enriched medium, IL-2R a chain expression persisted, al-
though at a lower frequency of cells than in the original BaF-3
cells (Fig. 2, lower histogram). The IL-2R a chain expression
in W53 cells is controlled by PRL in a dose-dependent man-
ner (Fig. 2, lower histograms). As discussed above, BaF-3
cells (PRL-R negative) were unable to survive when grown
only on PRL. These findings suggest that PRL signals, as well
as IL-3, participate in the up-regulation of the IL-2R a chain,
a characteristic change of the developmental transition from
B220lowCD431 pro-B to B220highCD432 pre-B cells.
PRL Increases the Amount of the Antiapoptotic Bcl-2,
but not Bcl-XL, Proteins in W53 Cells. A dominant influ-
ence of the cell survival machinery is relevant for lymphohe-
mopoietic differentiation to proceed with efficiency (27). Al-
though high proliferation rates of pro-B cells expand the size
of their pre-B-cell progeny, most are unsuccessful and later
die, with minor populations of death-resistant pre-B cells
evolving to final maturation and positive selection (28). Bcl-2
and Bcl-XL represent intracellular membrane-bound proteins
implicated in death antagonism in lymphoid lineages (29–
31). We tested whether their levels were altered by PRL-
driven signals in our experimental system by undertaking
intracellular immunofluorescence staining and Western blot
analysis with specific mAb. Flow cytometry analysis revealed
that Bcl-2 and Bcl-X proteins were constitutively expressed
both in BaF-3 and in W53 cells (Fig. 3A). Bcl-2 protein levels,
however, clearly increased (3–10-fold) in W53 cells at 30
ng/ml of PRL with respect to the levels obtained at 1 ng/ml.
Bcl-X basal expression, in contrast, was unmodified in W53
cells between the lowest and the highest PRL dosages (Fig.
3A). These observations were confirmed by Western blot
analysis (Fig. 3B). Although the Bcl-2 protein levels in-
creased, the expression of the Bcl-X long isoform, Bcl-XL
(the Mr 26,000 form of Bcl-X), remained unmodified in W53
Fig. 1. Transfection of the rat PRL-R into BaF-3 cells. A, BaF-3 and W53
cells (107 were biosynthetically labeled with L-[35S]methionine and
L-[35S]cysteine (200 mCi/ml) for 2 h. The supernatants from cell lysates
were immunoprecipitated sequentially with normal mouse serum, as pre-
immune control, and then with the anti-PRL-R U5 mAb. The immune
complexes were analyzed by SDS-9% PAGE and fluorography. Molecular
markers (in thousand) are at the left, and the position of the PRL-R is
indicated. B, W53 cells were seeded at 104 cells/well in 96-microwell
plates in complete medium supplemented with PRL. After 48 h, cell
cultures were pulsed overnight with 1 mCi of [3H]thymidine, harvested
[3H]-TdR), and the incorporated radioactivity was measured in a scintilla-
tion counter (35,591 6 818 cpm in BaF-3 cells 5 100%). Bars, SD.
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versus BaF-3 (Fig. 3B). These results indicate that PRL in-
creases the levels of antiapoptotic Bcl-2 protein in PRL-R-
transfected BaF-3 cells, providing them with a basal require-
ment to stimulate their B-cell differentiation.
Transcription of the pre-B Cell Receptor Encoding the
l5 Gene Is Strongly Stimulated by PRL in W53 Cells. A
critical requirement for normal B-cell differentiation is the
PBCR expression in the progenitors (32). The PBCR complex
is formed by the product of a fully rearranged Ig H chain
bound to those of invariant l5 and VpreB genes as a surro-
gate of light chains (33). l5 gene begins to be transcribed in
pro-B cells, and its encoded protein is present until the stage
of IgM1 B cells, where it is replaced by the products of
rearranged Ig light chains (28). We analyzed l5 gene expres-
sion in a specific, quantitative reverse transcription-PCR (34)
in BaF-3 cells and in W53 cells grown in IL-3 or in PRL. As a
presumably invariant gene, we also tested for b-actin gene
transcripts, and the 70Z/3 pre-B cell line was used as a
positive internal control of amplification (Fig. 4; Ref. 34).
BaF-3 pro-B cells showed very low levels of l5-specific
transcripts, corresponding to their early B-lineage character
(Fig. 4). In contrast, W53 cells displayed significant transcrip-
tional up-regulation of the l5 gene when stimulated by 30
ng/ml of PRL (10–100-fold of the basal values in different
experiments; P , 0.05 after applying two-tailed Student’s t
analyses; Fig. 4). This shows that PRL, upon its binding to the
receptor, triggers signaling pathways leading to increased
gene expression of the PBCR-encoding l5 gene, a neces-
sary requirement for normal B-cell differentiation.
In parallel to this study, we also tested for putative D-JH
immunoglobulin gene rearrangements with a genomic PCR
assay, which simultaneously reveals the four possible DJH1–4
rearrangements (34). In contrast with the l5 up-regulation
observed, the germ-line IgH pattern of BaF-3 cells showed
no modification to PRL signals (data not shown). We con-
clude from these data that PRL signaling positively regulates
the expression of l5 in the absence of evolving immunoglob-
ulin gene rearrangements.
PRL-R Expression Is Up-Regulated throughout Normal
Mouse B-Cell Differentiation. The findings obtained with
the PRL-R-transfected BaF-3 cells could be relevant to nor-
mal B-cell development if the PRL-R was present in B-cell
precursors. We decided to directly test this possibility in BM
B-cell precursors. B-cell differentiation starts with a small
population of B220lowCD43
1
pro-B cells that express the
CD43 antigen (Fig. 5, window of the upper contour plot).
Also, PBCR genes (l5 and VpreB) are transcribed, IgH gene
loci begin the ordered process of gene rearrangement, and
cells undergo l5-dependent high proliferation rates and
clonal expansion. Later, B220 antigen levels increase mod-
erately, CD43 is down-regulated, and precursors evolve to
the pre-B-cell stage (Fig. 5, window of the bottom contour
plot), in which most cells are resting and IgH gene rearrange-
ments are being completed, although these pre-B cells are
still surface IgM2. Finally, emerging B lymphocytes express
IgM before reaching their full maturation, when IgM and IgD
isotypes are expressed on the cell surface (28). We analyzed
the expression of PRL-R on B220lowCD431 pro-B cells and
B220highIgM2 pre-B cells, using the mouse-anti-rat PRL-R
U5 mAb (cross-reactive with the mouse receptor; Refs. 14
and 35) and three-color flow cytometry analyses. This study
revealed that the PRL-R was already expressed in a small
fraction of the B220lowCD431 pro-B-cell population. PRL-R-
positive cells were predominant in the next stage of
B220highIgM2 pre-B cells (Fig. 5, right histograms). PRL-R
expression has already been described in mature B lympho-
cytes (18). We did not analyze it in mature B cells because
the anti-PRL-R U5 mAb was a purified mouse immunoglob-
ulin and required a second incubation with a TC goat anti-
mouse immunoglobulin, which could not discriminate be-
tween the cell surface IgM and the PRL-R signals on the
same B cell. We conclude that the PRL-R is expressed in
mouse B-cell progenitor populations from the earliest stages
of B-lineage differentiation (pro-B cells).
Effects of PRL on Short-Term Cultures of BM-derived
B-Cell Precursors. Both the findings obtained in the BaF-
3/W53 cell system and the detection of PRL-R in BM B-cell
precursors led us to analyze the putative PRL effects on
primary B-cell precursors. We then established enriched BM
B-cell precursors in cultures supported by the S17 stromal
cell line and IL-7, as described by other authors (36). Titrated
doses of PRL (1–1000 ng/ml) were added at the start point of
cultures, and changes induced were studied 4 days later.
Absolute cell recoveries of BM B-lineage cell cultures signif-
icantly increased upon addition of PRL to the medium (P ,
0.05 between the basal conditions and the cultures supplied
by 100 and 1000 ng/ml of PRL) in a dose-dependent manner
(Fig. 6A). During the 4 days of BM cell culture, many of the
predominant CD431B2201 pro-B cells of the starting
cultures (;70% in different experiments) evolved to
Fig. 2. PRL induces the IL-2R a chain on PRL-R W53 transfected cells.
Expression of B-lineage markers was analyzed by flow cytometry in BaF-3
cells and in W53 cells grown in PRL-enriched medium during 4 days. Cells
(5 3 105) were incubated with biotin-conjugated PC61 mAb and then
revealed with streptavidin-PE. Expression of IL-2R a chain in BaF-3 cells
growth in IL-3-enriched medium (upper histogram) and in W53 cells grown
in IL-3 or with titrated doses of PRL (. . . 0.3, — 3, 30 ng/ml; bottom
histograms) are shown. The background signals, provided by isotype-
matched irrelevant mAb in both BaF-3 and W53 cells, were adjusted
during cell acquisition, and they are displayed in the shaded histograms
for both cell lines. The percentages of IL-2R a chain1 cells are shown at
the upper right corner of the histograms. This is one representative ex-
periment of four independent analyses.
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CD432B2201 pre-B cells (contour plots, Fig. 6B), and IgM1
B cells appeared de novo (histograms, Fig. 6B). Right column
graphs display the absolute cell recoveries/ml of total B2201,
CD431B2201, and B2201IgM1 cells, both in basal condi-
tions and upon the addition of titrated doses of PRL. All of
these cell subsets increased on a PRL dose-dependent ba-
sis, expansions that were more remarkable for total B2201
cells (most of them pre-B cells) and CD431B2201 pro-B
cells. IgM1 B cells underwent more moderate, although PRL
dose-dependent, increases. We conclude that PRL induces
selective augmentations of normal B2201 B-lineage cells
established in vitro, more specifically, of CD431B2201 pro-B
cells.
Discussion
The generation and cell turnover of lymphohemopoietic lin-
eages are very active throughout the lifespan of the individ-
ual. These processes are submitted to the regulatory control
of intercellular interactions and soluble factors acting in au-
tocrine, paracrine, and endocrine manners. In the work re-
ported here, we have analyzed the putative involvement of
PRL in mouse B-cell development by transfection of the rat
PRL-R in BaF-3 pro-B cells and through the study of PRL
influences over short-term cultures of BM pro-B cells. When
PRL-R-tranfected BaF-3 cells were studied, we found, as
compared with cells transfected with the empty vector, that:
(a) the expression of IL-2R a chain, a characteristic of late
pre-B cells, was dependent on signals triggered by either
IL-3 and/or PRL; (b) antiapoptotic Bcl-2 protein levels were
increased by PRL; and (c) transcription of the PBCR-encod-
ing l5 gene was strongly and specifically activated by PRL-
dependent stimuli. We also observed that PRL-R was ex-
pressed in normal BM B-cell progenitors. PRL induced, in
dose-dependent manner, the expansion of discrete B-line-
age cell populations in short-term BM cultures. Collectively,
these data suggest that PRL modulates the differentiation
program of mouse B-cell progenitors.
Recently, genetic disruptions of both PRL-R and PRL
genes in the mouse have been reported (37, 38). As ex-
pected, important disturbances in reproductive capacity and
in mammopoiesis took place in the homozygous mice. In
contrast, no drastic deficiencies were found on lymphohe-
mopoiesis in PRL (2/2) mice (38), although the absolute
numbers of splenocytes and the levels of splenic B cells were
reduced in them. Since this animal model has not revealed
yet a critical requirement for PRL in lymphohemopoiesis, it is
possible that the putative role of PRL in B cell development
is replaced by reduntant factors. This has been shown to be
the case for other gene products, as it is exemplified by
members of the Src family (reviewed in Ref. 39).
BaF-3 pro-B cells were established in IL-3-dependent
conditions, and they represent one of the earliest B-cell
differentiation stages (25), while maintaining some degree of
flexibility to develop through other hemopoietic lineages.
Fig. 3. PRL-dependent up-regulation of the Bcl-2 protein. A, Bcl-2 and
Bcl-X protein levels were quantified by intracellular stainings of cells
incubated for 20 min on ice with the specific mAb diluted in 0.5% sapo-
nin/2% FCS/PBS and later revealed with FITC-labeled anti-hamster im-
munoglobulin antibody. Background signals of irrelevant mAbs were elec-
tronically adjusted during cell acquisition. —, BaF-3 1 IL-3; - - -, W53 1
IL-3; . . . ., W53 1 1 ng/ml PRL; , W53 1 30 ng/ml PRL. This is one
representative of three independent experiments (days 3–5 of the cell
culture). B, Bcl-2 and Bcl-XL protein expression levels were determined by
Western blot analysis on total cell extracts of BaF-3 cells 1 IL-3 and W53
cells 1 30 ng/ml PRL, as described in “Materials and Methods.”
Fig. 4. Transcription of the l5 gene is selectively increased by PRL-
induced signals. The levels of l5 transcripts were studied in both BaF-3
and W53 cel lines (grown either in IL-3 or in 30 ng/ml of PRL). Total mRNA
was extracted and retrotranscribed to cDNA, and a quantitative PCR was
performed to amplify a 630-bp fragment of the l5 mRNA sequence, as
described (34). A control PCR for b-actin amplification was done to
estimate the amount of cDNA in each sample. PCR products were sep-
arated by electrophoresis and transferred to Zeta-probe membranes.
Signals obtained after hybridization with specific probes were quantified
by densitomentry, and the ratio between l5 and b-actin signals was
calculated (bottom column graph). The later data represent means of four
different experiments and are shown in a logarithmic scale; bars, SD. The
70Z/3 pre-B cell line was used as a positive control of the amplification
reaction.
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They were, however, resistant to complete B-cell differenti-
ation associated with immunoglobulin secretion (25). We also
found that under no conditions, including in vivo transfer to
SCID mice, were they able to rearrange their immunoglobulin
genes, probably due to the lack of RAG-1 gene transcription
(as confirmed in specific reverse transcription-PCR, data not
shown). When BaF-3 cells were transfected with PRL-R, the
resultant W53 cells integrated PRL signals, grew in IL-3
deprived, PRL-enriched media, and expressed parameters
of B-cell differentiation. In particular, B lineage-specific l5
gene transcription was strongly up-regulated. This gene en-
codes part of the PBCR, it is first expressed on pro-B cells,
and its deletion blocks most of B lymphopoiesis (32). It plays
a role in the clonal expansion of B-cell precursors by induc-
tion of proliferative stimuli or by activation of cell survival
machinery, or both. Very little is known about l5 gene reg-
ulation, but our findings show that the signaling pathways
triggered by PRL-R lead to the up-regulation of l5 gene
expression in BaF-3 cells. Recently, the synergistic action of
EBF and E47 transcription factors on the induction of l5
expression has been observed in BaF-3 cells (40). l5 gene
enhancer also contains binding sites for Pax-5/BSAP (41).
Future experiments will clarify whether the PRL-induced
changes of l5 gene expression in W53 cells are mediated by
any of these transcription factors.
In addition, we have found that IL-2R a chain expression,
which appears in normal BM pre-B cells after the pro-B-cell
stage (20, 28), is positively regulated by PRL in W53 cells as
well as by IL-3 in BaF-3 and in other cell lines (26). Antiapo-
ptotic Bcl-2, but not Bcl-XL, protein levels were also aug-
mented by PRL in W53 cells in a dose-dependent manner.
Bcl-2 shows developmental expression patterns; its up-
regulation is linked to the positive selection of immature cells
(30, 42, 43). PRL-dependent control of Bcl-2 protein levels
has also been described in rat Nb2 thymoma cells (44). Other
members of the type I cytokine receptor superfamily also
influence the expression of Bcl-2 (45) and thus provide
separate mitogenic and antiapoptotic signals. The observed
changes suggest that PRL signals are able to provide some
critical requirements for the intrinsic differentiation program
of BaF-3 pro-B cells to be fully expressed, as it has been
described in other systems (46–48). The finding of PRL-R
expression in normal B-cell precursors and the PRL-depend-
ent increases of in vitro-established B-lineage cells provide
evidence for the physiological relevance of this endocrine
pathway as an additional support for normal B-cell differen-
tiation. It is worth noting that some of the above differentia-
tion changes of W53 cells in response to PRL may be inter-
connected in a network of genetic interactions (49). Bcl-2
may thus respond to increased IL-2R- or l5-dependent sig-
nals (45) and vice versa; the set-up of cell survival machinery
could be a basic condition for the evolution of progenitors to
more differentiated stages (27). All of these parameters of
BaF-3 cell differentiation in the absence of immunoglobulin
rearrangements further support the proposal of Grawunder
et al. (50) about the existence of two autonomous programs
of B-cell differentiation, one characterized by changes in
surface receptors and growth requirements and another af-
fecting immunoglobulin gene rearrangement. Both differen-
tiation modules contribute to generate a functional mature B
lymphocyte, and PRL may be selectively acting on the first
one.
In more physiological conditions, the in vitro expansion/
differentiation of normal BM pro-B cells was thus stimulated
by PRL in our experiments. Other studies have shown that
both estrogens (during pregnancy) and PRL (after delivery)
suppress B lymphopoiesis (21). The data described here do
not necessarily diverge from the later ones (21), because
proliferation and differentiation may be two partially opposite
cell fates of the same activation stimulus. As an overall
conclusion, these findings obtained under in vitro conditions
suggest the involvement of PRL in early stages of B-cell
differentiation. The results also provide an experimental
model (BaF-3/W53) with well-controlled genetic targets (l5,
IL-2R a, and Bcl-2) to dissect the pathways of PRL-R sig-
naling in lymphohemopoietic cell lineages.
Materials and Methods
Mice, Cell Cultures, and Cytokines. The mouse IL-3-dependent BaF-3
cell line (25) was cultured in RPMI 1640 supplemented with 10% FCS (Life
Technologies, Inc., Renfrewshire, United Kingdom) and 5% of WEHI-3B
supernatant as a source of IL-3 (51). BaF-3-derived W53 cell line (PRL-R
transfectants) was cultured in RPMI 1640/10% FCS and different doses of
ovine PRL (NIDDK-oPRL-20, 31 IU/mg; a gift of the National Hormone and
Pituitary Program, Bethesda, MD).
BALB/c females, 3 months of age, maintained in the animal facilities of
the CBMSO, were sacrificed for BM cell isolation. The BM was flushed out
by injection of balanced salt solution 5% FCS into the femur and disrupted
with a 1-ml syringe to obtain a single-cell suspension. The small subset of
BM B2201CD431 pro-B cells was purified in a two-step process: (a)
staining of total BM cells with both biotinylated anti-Mac-1 and anti-IgM
mAb (see “Antibodies”) and indirect magnetic labeling with Streptavidin
Fig. 5. Expression of the PRL-R in mouse BM pro-B and pre-B cells.
Three-color flow cytometry analyses were performed on BM cells as
described in “Materials and Methods.” BM cells (5 3 105) were incubated
with either FITC-anti-CD43 or FITC-anti-IgM, together with PE-anti-B220
and purified mouse anti-rat PRL-R U5 mAb. This later was revealed with
TC-conjugated, goat-anti-mouse immunoglobulin. Pro-B cells were de-
fined as B220lowCD431, and they represented 3–4% of total BM (window
of the upper control plot). Pre-B cells were included in the B220highIgM23
window (8–10% of total BM; window of the bottom contour plot). Right
histograms, PRL-R expression on pro-B and pre-B cell populations.
Shaded histograms, background signals of isotype-matched, irrelevant
mAb. The data are representative of three independent experiments.
Fluorescence signals are displayed in logarithmic scales.
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microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany), followed by
their negative selection with a MiniMacs magnet (Miltenyi Biotec), and (b)
staining of remaining IgM2 Mac-12 cell fraction with rat anti-CD43 mAb
(see “Antibodies”), labeling with goat-anti-rat microbeads (Miltenyi Bio-
tec), and positive selection of CD431 cells. Magnetic cell sorting protocols
followed the indications of the supplier. B-cell-supporting S17 cells were
grown to confluence, treated with Mitomycin C (Sigma Chemical Co., St.
Louis, MO), and replated at a density of 0.5 3 106 cells/24-well plate, as
described (36). Then B2201CD431 cells (106/ml) were added to the cul-
tures in medium containing limiting amounts of mouse IL-7 (10 units/ml;
Sigma) and titrated doses of PRL. The changes produced in the cultures
were analyzed at day 4 of evolution.
Cloning and Expression of the PRL-R. The original cDNA clone of
the long form of PRL-R from rat ovary was generously provided by Dr.
P. A. Kelly (INSERM, Paris, France; Ref. 52). Its 59 and 39 noncoding
sequences were eliminated by PCR using the 59 oligonucleotide contain-
ing the starting codon (59-CTGAAGGAAT TCATGCCATCTGCACT-39) and
the 39 oligonucleotide containing the stop codon (59-CGGGGT ACCGTC-
GACTCAGTGAAAGGAGTGCATGAAGC-39). The PCR amplified product
was digested with EcoRI and SalI, cloned in pBluescript (Stratagene, La
Jolla, CA), and checked by sequencing. The cDNA coding region was
excised from the pBluescript with EcoRI and SalI and recloned into the
pBabe-Puro retroviral vector (53). In this vector, the expression of the
exogenous cDNA is driven by the long terminal repeat of the Moloney
leukemia virus.
The pBabe-Puro plasmid containing the PRL-R or the empty vector (50
mg each) was transfected into BaF-3 cells (107) by electroporation at 956
mF and 350 V in a Bio-Rad apparatus (Bio-Rad, Hercules, CA). After 48 h
in complete medium, transfected cultures were selected in complete
medium containing 4 mg/ml of puromycin. Two weeks later, cells trans-
fected with the PRL-R were transferred to RPMI 1640 supplemented with
10% FCS and 1 mg/ml of PRL. Subsequently, the hormone concentration
was progressively reduced to a final concentration of 1 ng/ml, in which the
cells have been maintained for .1 year; the resulting cell line was named
W53. Cells transfected with the empty vector were maintained in complete
medium containing 1 mg/ml of puromycin.
Cell Labeling, Immunoprecipitation, and Western Blot. For biosyn-
thetic labeling, BaF-3 and W53 cells were deprived of FCS and PRL by
incubation in RPMI 1640 supplemented with 3% detoxified bovine serum
albumin (BSA Fraction V; Sigma) overnight. The cells were then incubated
in methionine-free DMEM (30 min at 37°C), washed, and submitted to a
second incubation for 2 h in the presence of 1 ng/ml of PRL, L-[35S]me-
thionine and L-[35S]cysteine (200 mCi/ml; Amersham, Inc.). Cells were
collected by centrifugation (1500 3 g for 5 min at 4°C), washed with
ice-cold Tris-buffered saline [10 mM Tris-HCl (pH 7.4), 150 mM NaCl], and
then solubilized in ice-cold lysis buffer [LB: 10 mM Tris-HCl (pH 7.4), 10 mM
Na4P2O7 (pH 7.4), 80 mM NaCl, 50 mM NaF, 5 mM EDTA, 100 mM Na3VO4,
1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine,
1 mM 1,10-phenanthroline, and 1 mM iodoacetamide]. The cell lysates
were spun (17,500 3 g for 30 min at 4°C), the supernatants were trans-
ferred to new tubes, and their protein concentration was measured. These
supernatants, equalized for protein concentration, were incubated for 1 h
at 4°C with 30 ml of protein G-Sepharose (Sigma) and then centrifuged
(3300 3 g for 2 min at 4°C). The precleared supernatants were incubated
under the same conditions with 30 ml of normal mouse serum Ig-protein
G-Sepharose, which was bound and washed previously. The pellets ob-
tained after this incubation were stored on ice and used as preimmune
complexes. After being transferred to new tubes, the supernatants were
incubated as before with 30 ml of purified mouse anti-rat PRL-R U5 mAb
(5 mg; Affinity Bioreagents, Inc., Golden, CO) IgG1-protein G-Sepharose.
The supernatants were discarded, and the pellets were washed three
times with ice-cold LB. The preimmune and the immune complexes were
extracted twice by boiling in 40 ml of 23 SDS sample buffer and resolved
in a SDS-9% PAGE under reducing conditions. The biosynthetically la-
beled PRL-R was detected by fluorography in the gel.
For analyzing the expression of Bcl-2 and Bcl-XL from the supernatants
of cell lysates by Western blot, aliquots containing 20 mg of protein were
boiled in 23 SDS Laemmli sample buffer, resolved in a SDS-12% PAGE
Fig. 6. Effects of PRL on short-term cul-
tures of purified mouse B-cell precursors.
BM pro-B cells were purified by a two-
step separation protocol with immuno-
magnetic beads, which included negative
selection of IgM1 and Mac-11 cells, and
positive recovery of CD431 cells, most of
them B2201 (Day 0 contour plot of B). The
titrated doses of PRL shown in the figure
were added to the cultures at day 0, and
the induced changes were analyzed 4
days later. A, absolute cell recoveries af-
ter 4 days of culture were quantified after
Trypan blue exclusion (mean of three in-
dependent cell cultures; bars, SD; p, sam-
ples significantly different from the first
column, which represents cell cultures
without added PRL; P , 0.05). B, display
of cell populations at the startpoint and 4
days later (contour plots and histograms).
The absolute cell recoveries shown in the
right column histograms were calculated
from the relative cell numbers obtained by
flow cytometry (inside the displayed win-
dows of the contour plots and the positive
cells of the histograms) and the total cell
recovery/well of one representative ex-
periment.
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under reducing conditions, and transferred to polyvinylidene difluoride
membranes (Immobilon; Millipore Corp., Bedford, MA). Filters were
blocked with 5% fat-free dried milk (Fluka Chemie AG, Buchs, Switzer-
land) in TTBS (Tris-buffed saline, 0.1% Tween 20), incubated with the
primary antibody in blocking buffer, washed three times with TTBS, and
further incubated with the suitable horseradish peroxidase-conjugated,
anti-species-specific antibody (TAGO Immunologicals, Camarillo, CA).
Proteins were visualized by enhanced chemiluminiscence (ECL; Amer-
sham).
Antibodies and Flow Cytometry Analysis. The following mAbs were
purified from culture supernatants by affinity chromatography on protein
G columns (Pharmacia Biotech, Uppsala, Sweden) and biotinylated by
standard methods: anti-IgMa (RS3.1; Ref. 54), anti-Mac-1 (M1/70; Ref.
55), and anti-IL-2R a chain (PC61; Ref. 56). Phycoerythrin-conjugated
anti-B220 (RA3-6B2), fluorescein-conjugated (FITC) anti-CD43 (Leukosia-
lin, S7), purified goat-anti-mouse IgM, anti-Bcl-2, and anti-Bcl-X were
purchased from Pharmingen (San Diego, CA). FITC-goat anti-hamster
immunoglobulin and streptavidin-PE were obtained from Southern Biot.
(Birmingham, AL). TriColor-conjugated goat-anti-mouse immunoglobulin
and FITC goat-anti-rabbit immunoglobulin were from Caltag Laboratory
(San Francisco, CA). For Western blot detection of Bcl-2 and Bcl-XL, the
anti-Bcl-2 rabbit polyclonal antibody N-19 from Santa Cruz Biotechnology
(Sana Cruz, CA) and the anti-Bcl-X mouse mAb B22620 from Transduc-
tion Laboratories (Lexington, KY) were used. Affinity-isolated, horseradish
peroxidase-conjugated goat-anti-rabbit and goat-anti-mouse antibodies
were from TAGO.
Cells were dissociated from BM or harvested from cultures, washed,
and resuspended in staining solution (PBS, 2% FCS, and 0.1% sodium
azide) at a density of 5 3 106/ml. For cell surface stainings, cells were
incubated in optimal concentrations of either biotinylated or fluorescein-
ated mAb on ice for 20 min. When required, streptavidlin-PE was added
after washing and incubated on ice for 20 min. Cell debris and dead cells
were excluded by light scatter parameters and propidium iodide staining
(50 mg/ml of propidium iodide in the staining solution). Background signals
were set by incubating cells with isotype-matched irrelevant mAb. The
minimum number of acquired cells/sample was always 5000 cells. Intra-
cellular stainings were performed by incubating the cells with the purified
mAb diluted in 0.5% saponin (Sigma), 2% FCS in PBS (20 min on ice).
After washing, cells were incubated with either FITC-labeled goat-anti-
hamster Ig or goat-anti-rabbit Ig for Bcl-2 and Bcl-X detection, respec-
tively. For three-color stainings, 5 3 105 BM cells were incubated with
either FITC-labeled anti-CD43 or goat-anti-IgM, PE-labeled anti-B220 and
purified mouse-anti-rat PRL-R U5 mAb (20 min on ice). After washing, the
purified antibody was revealed with TC-goat-anti-mouse immunoglobulin
in a second incubation. Flow cytometry analyses were performed on an
EPICS-XL flow cytometer (Coulter Corp., Hialeah, FL).
RT-PCR Analyses. Total RNA was extracted, and equal amounts of
each sample were reverse-transcribed as described (57), by using 1 mg
oligo(dT) as primer and avian myeloblastosis virus reverse transcriptase
(AMV-RT; Promega, Madison, WI). For quantitative PCR amplifications of
b-actin and l5 cDNAs, 2.5 units of Taq polymerase (DNAzyme, Espoo,
Finland) were added to each sample, together with the specific primers
(34). After an initial denaturation step (95°C for 5 min), b-actin and l5
transcripts were amplified for 18 and 40 cycles, respectively, before a final
10-min incubation at 72°C. Each cycle consisted of the following steps: 1
min at 95°C, 1 min at 60°C, and 1 min at 72°C. One-fifth of the amplified
products was separated electrophoretically on 2% agarose gels and then
transferred to Zeta-probe membranes (Bio-Rad) after 0.4 M NaOH treat-
ment. Hybridization of the membranes was performed at 65°C by using
random priming 32P-labeled b-actin and l5 probes that have been de-
scribed elsewhere (34). Membranes were washed, and the PCR signals
were detected and quantified by densitometry in a Fujibas-1000 detector
(Fuji, Tokyo, Japan).
Cell Proliferation. Cell proliferation rates were obtained after an over-
night pulse with 1 mCi of [3H]thymidine (Amersham). Cells (104) per well in
triplicates were plated on 96-well, flat-bottomed plates (Nunc), cultured
for 2 days, and then pulsed as above. Cells were then harvested onto
glass fiber filters, and the incorporated radioactivity was quantified by a
scintillation counter (Wallac LKB, Turku, Finland).
Statistical Analysis. The two-tailed Student’s t test and Mann-Whit-
ney rank sum test were used to compare variables between groups.
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